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Clarisse M. Machado1Respiratory syncytial virus (RSV) is recognized as the leading cause of nosocomial respiratory infection
among hematopoietic stem cell transplant (HSCT) recipients, causing considerable morbidity and mortality.
RSV is easily transmitted by contact with contaminated surfaces, and in HSCTunits, more than 50% of RSV
infections have been characterized as of nosocomial origin. FromApril 2001 toOctober 2002, RSV was iden-
tified by direct immunofluorescent assay in 42 symptomatic HSCTrecipients. Seven RSV strains from 2001
and 12 RSV strains from 2002 were sequenced. RNA extraction, cDNA synthesis, and seminested polymer-
ase chain reaction (PCR) with primers complementary to RSV genes G and F were performed. PCR products
were analyzed by nucleotide sequencing of the C-terminal region of gene G for typing (in group A or B). Of
the 7 strains analyzed in 2001, only 2 belonged to group B; the other 5 belonged to group A. Of these 7
strains, 3 were identical and were from recipients receiving outpatient care. In 2002, of the 12 strains ana-
lyzed, 3 belonged to group A and the other 9 belonged to group B. Of these 9 strains, 7 were genetically
identical and were also from recipients receiving outpatient care. Therefore, multiple strains of RSV cocircu-
lated in the hematopoietic stem cell transplant units (ward and outpatient units) between 2001 and 2002.
Nosocomial transmission was more likely to occur at the HSCT outpatient unit than in the HSCTward.
Infection control practices should also be implemented in the outpatient setting.
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Nosocomial transmission, Outpatient careINTRODUCTION
Respiratory syncytial virus (RSV) infection can
cause significant morbidity and mortality in hemato-
poietic stem cell transplant (HSCT) recipients. RSV
circulates throughout the year, but increased activity
is observed in late fall and winter in countries with
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/08/1412-0001$34.00/0
6/j.bbmt.2008.09.012RSV is classified in the genus Pneumovirus, sub-
family Pneumovirinae, family Paramyxoviridae. Two
antigenic groups of RSV (A and B) have been described
on the basis of reactions with monoclonal antibodies
(mAbs) specific for the G protein, the most variable
gene product among RSV isolates. Nucleotide se-
quencing has shown that, at the amino acid level, there
is only 53% identity between the G proteins of the
prototype strains of groups A and B, and up to 20% se-
quence variation has been observed among the G pro-
teins of RSV isolates of the same antigenic group [1].
Sequencing of phylogenetically informative regions
of the G gene has been useful in identifying lineages
(or genotypes) of RSV within the 2 major groups and
in refining our ability to differentiate between RSV
isolates. Therefore, phylogenetic analysis has been
recommended for epidemiologic investigation of
RSV outbreaks [2].
Respiratory viruses (RV) are easily transmitted by
contact with contaminated surfaces. In HSCT units,
more than 50% of RSV infections have been
Biol Blood Marrow Transplant 14:1348-1355, 2008 1349Respiratory Syncytial Virus: Community or Nosocomial Infection?characterized as of nosocomial origin, based on the in-
terval between patient admission and the diagnosis of
RSV infection [3,4]. More recent studies have used
molecular epidemiology to better characterize RSV
transmission in hospital outbreaks [5,6]. American
and European guidelines recommend strict infection-
control measures to limit RSV transmission in
HSCT units [7]. However, the implementation of
such policies is limited in the outpatient setting, and,
therefore, transmission is likely to occur.
Although previous studies have highlighted the
possibility of nosocomial transmission, molecular
characterization of RSV strains during the RV season
and the mechanisms involved in RSV transmission
have been poorly addressed, especially in the outpa-
tient setting.PATIENTS AND METHODS
Study Population
Nasal wash (NW) samples from HSCT recipients
with symptoms of upper respiratory tract infection
were collected in 2001 and 2002. NWs were also taken
from 37 symptomatic health care workers (HCW) who
assisted the HSCT recipients during the study period.
The samples were collected according to Englund
et al. [8] and processed within 2 hours of sampling by
direct immunofluorescent assay (DFA) (Imagen
Dako, Cambridgeshire, UK), which allows rapid diag-
nosis of the most relevant RV infections. The remain-
ing material was stored at 280C.
RSV infection was diagnosed by DFA in 21 of the
141 patients tested in 2001, 21 of the 181 patients
tested in 2002, and in 13 of the 172 patients tested in
2003 [9]. These patients were either hospitalized in
the HSCT unit at the Hospital das Clınicas, Faculty
of Medical Sciences, University of Sa˜o Paulo (HC-
FMUSP), or attending the outpatient unit at the
same hospital.
RV infection was detected in 6 HCWs (16.2%):
RSV was diagnosed in 1 HCW (2.7%), influenza A
in 3 (8.1%), and influenza B in 2 (5.4%).Facilities and Infection Control Policies
The inpatient unit of the BoneMarrowTransplant
Division has rooms with filtered air and positive pres-
sure. HSCT recipients are hospitalized in single rooms
either prior to the transplant or in the event of post-
transplant complications. The control of RV transmis-
sion in the HSCT unit includes the following
measures: (1) influenza vaccination is recommended
for all HSCT recipients after the sixth month of trans-
plantation for family members and HCWs, (2) NW
samples are taken from all symptomatic patients to
test for respiratory virus using the DFA, (3) symptom-
atic patients are kept under contact precautions untila specific diagnosis is made, (4) patients who test pos-
itive for respiratory viruses are transferred from rooms
with positive pressure to rooms without positive pres-
sure, (5) HCWs with respiratory symptoms are tested
for respiratory virus infection, (6) visits by children un-
der 12 years of age are forbidden during the respiratory
virus season.
The outpatient unit operates from 7am to 7pm
hours and attends patients at various stages after trans-
plant for medical care or laboratory tests. Patients
share a small waiting room, as well as the bathrooms
and treatment room, where there are 6 reclining chairs.
NW samples were collected in the treatment room by
the nurses wearing a mask, gown, and gloves. Patients
were seen by a physician in a separate room (consulting
room), which was also used to ‘‘cohort’’ patients with
respiratory virus infections who needed to stay in the
outpatient unit. The control of RV infections in the
outpatient unit included the following measures: (1)
NWs were collected from all symptomatic patients
to test for respiratory viruses usingDFA, (2) face masks
were used in the unit when patients had symptoms of
respiratory infection and/or a respiratory virus was de-
tected, (3) disposable sheets were used on the reclining
chairs, and (4) when available, individual consulting
rooms were used for patients with RV infections who
needed to stay in the outpatient unit or, failing this,
patients were cohorted according to the virus detected.
Definition of RSV Nosocomial Infection
A patient was considered to have nosocomial RSV
infection in the presence of signs and symptoms of re-
spiratory disease in the upper and/or lower respiratory
tract together with the following criteria: (1) no signs
or symptoms of respiratory disease on admission, (2)
NW sample tested negative for RSV by DFA on ad-
mission, and (3) positive DFA test at least 5 days after
admission, based on the average incubation period for
RSV infection, according to Garcia et al. [10].
RNA Extraction, Reverse Transcription
Polymerase Chain Reaction (PCR), and DNA
Sequencing
The RNA of the samples that tested positive for
RSV by DFA was extracted by the silica gel method
(NucliSens). cDNA was synthesized using random
primers, and a seminested PCR was performed with
primers complementary to the fusion protein (F) and
attachment protein (G). The following 3 primers
were used: GAB (YCA YTT TGA AGT GTT CAA
CTT) [11], FV (GTT ATG ACA CTG GTA TAC
CAA CC) [12], and F1AB (CAA CTC CAT TGT
TAT TTG CC) [13].
The PCR products were purified with a Microcon
Purification kit (Millipore, Bedford, MA). GAB and
F1AB primers and the Big Dye v2.0 kit (Applied
1350 Biol Blood Marrow Transplant 14:1348-1355, 2008A. F. Machado et al.Biosystems, Bedford, MA) were used for the sequenc-
ing reaction performed on an ABI PRISM 377 DNA
sequencer (Applied Biosystems Inc.).
Nucleotide Sequence Analysis
Electropherograms were analyzed using the Seq-
Man PC program (DNASTAR Inc., Madison, WI)
to obtain a 270-nucleotide sequence corresponding
to the second variable region of the glycoprotein G
gene (G2), including nucleotides 649-918 and 652-
921 for RSVA and B, respectively [9]. The contigs cor-
responding to the G2 region were aligned in 2 groups
(A and B) using the ClustalX program and converted
into NEXUS format.
To determine whether the RSV strains circulating
in both HSCT units were similar to community
strains, sequences of community-acquired RSV ob-
tained from children seen at the emergency room of
the University Hospital, University of Sa˜o Paulo,
from 2001 to 2002 were included in the analysis.
Two sequences of RSV isolated from HSCT recipi-
ents in 2003 were also included in the analysis to estab-
lish the persistence of strains in consecutive years.
Phylogenetic Analysis
Sequence alignment for groups A and B was per-
formed using the multiple sequence alignment method
implemented in ClustalX. Maximum likelihood (ML)
analysis was performed using PAUP*4.0 b10 (Sinauer
Associates Inc., Sunderland, MA) for Power Macin-
tosh and Unix [14].Table 1. RSV Group and Genotype of Patients Infected in
2001 and 2002
Year Patient No. RSV Group Genotype Location
2001 687 B SAB1 Outpatient unit
2001 997 A GA2 Outpatient unit
2001 445 B SAB1 Outpatient unit
2001 1034 A GA2 Outpatient unit
2001 1032 A GA2 Outpatient unit
2001 1023 A GA5 Hospital HSCTward
2001 1152 A GA5 Outpatient unit
2002 147 A GA2 Outpatient unit
2002 1322 B SAB3 Outpatient unit
2002 1329 B SAB3 Outpatient unit
2002 1370 B SAB3 Outpatient unit
2002 1321 B SAB3 Outpatient unit
2002 1149 B SAB3 Outpatient unit
2002 817 A GA2 Outpatient unit
2002 1220 A GA5 Outpatient unit
2002 1328 B SAB3 Outpatient unit
2002 858 B SAB1 Outpatient unit
2002 1248 B SAB1 Outpatient unit
2002 1308 B SAB3 Outpatient unitRESULTS
Samples Studied
Of the 21 samples that were positive for respiratory
syncytial virus by DFA in 2001, only 7 could be ana-
lyzed for the following reasons: (1) some samples
were not stored because of insufficient material after
DFA processing, (2) in some samples the RNA was
lost, possibly because of a delay in processing and/or
inadequate storage, or (3) amplified product was inad-
equate for sequencing. Similarly, of the 20 positive
samples in 2002, only 12 could be analyzed. Of the
19 virus strains analyzed, 11 were from females and 8
from males; the underlying diseases were chronic
myelogenous leukemia(CML) in 9 patients, acute
myelogenous leukemia(AML) in 6, multiple myelo-
ma(MM) in 3 and non-Hodgkin’s lymphoma(NHL)
in 1 patient. Eighteen patients were receiving medical
care at the outpatient unit.
Analysis of Virus Strains in 2001 and 2002
In 2001, samples from 7 patients were analyzed, 6
of whom were receiving outpatient care when RSVinfection was diagnosed. Of these 7 strains, 5 belonged
to group A (71.4%) and 2 to group B. The predomi-
nant genotype for that year in our patient population
was GA2, followed by GA5 and SAB1 (Table 1). The
predominant strains circulating in the community in
the same year belonged to group B (E.L. Durigon, per-
sonal communication, data not published).
Three of the 5 strains from group A (60%), iden-
tified in 2001, were considered to be very closely
related phylogenetically (TMO9971, TMO10321,
and TMO10341; Figure 1). All 3 patients were re-
ceiving outpatient care.
In 2002, samples from 12 patients were analyzed,
all of whom were receiving outpatient care when the
infection was diagnosed. Whereas the predominant
RSV strains circulating in the community in 2002
were from group A (E.L. Durigon, personal communi-
cation, data not published), 9 of the 12 strains (66.6%)
from HSCT recipients receiving outpatient care be-
longed to group B (Table 1).
Seven of the 9 strains from group B in 2002
(77.7%) were considered phylogenetically identical
(TMO13222, TMO13292, TMO13702, TMO13212,
TMO11492, TMO13282, and TMO13082; Figure 2).
The predominant genotype for that year was SAB3, fol-
lowed by SAB1 and GA2 (Table 1).
Further data on RSV infection in 2001 and 2002,
according to month of diagnosis and day of outpatient
visits are shown in Figure 3.DISCUSSION
Sa˜o Paulo is a city with a subtropical climate in the
southeast region of Brazil. In general, respiratory vi-
ruses circulate year round with similar activity except
Figure 1. Phylogenetic tree constructed using the maximum-likelihood method for samples from RSV group A.
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which peak in fall and winter, respectively. The start
of the RSV season in Sa˜o Paulo was in April 2001
and in March 2003. In 2001, the peak occurred in
May, and cases were registered until the end of the
winter that year, in agreement with data from other
regions in Brazil with the same climate [15]. In 2002,
the RSV season had a peak at the end of fall/beginning
of winter and lasted until the beginning of spring, in
October.
To prevent nosocomial transmission, it is recom-
mended that for patients with established RSV: (1)
separate rooms should be used; (2) individual equip-
ment, such as pulse oximeters, electronic thermome-ters, stethoscope, etc., should be used; (3) a contact
precaution sign should be placed on the patients’
door; and (4) contact isolation precautions should be
used, such as cohort nursing, wearing of gown and
gloves, and strict attention to good hand washing prac-
tices in any contact with the infected patient [16].
Such measures are difficult to implement in the
outpatient setting. In this study, most of the virus
strains analyzed in 2001 and 2002 were from patients
who had been attending the outpatient department
of the HSCT unit. Two clusters of closely related
strains were found in the ML analysis: 1 in 2001 with
group A strains of RSV (TMO9971, TMO10321,
and TMO10341), and the other in 2002, with group
Figure 2. Phylogenetic tree constructed using the maximum-likelihood method for samples from RSV group B.
1352 Biol Blood Marrow Transplant 14:1348-1355, 2008A. F. Machado et al.B strains (TMO13702, TMO13222, TMO13292,
TMO13212, TMO11492, TMO13282, and
TMO13082).
Some of the patients infected in 2002 attended the
outpatient unit on the same day or within a few days of
each other. Interestingly, the strains identified in these
patients were from group B, different from those circu-
lating in the community that year (group A). These
observations suggest that transmission may have taken
place within the outpatient unit as a result of the small
area shared by patients and the difficulty in implement-
ing RSV control measures in this area. Nichols et al.
[17] observed evidence of crosstransmission of the par-
ainfluenza-3 virus, which also belongs to the Paramyx-
oviridae family, in the outpatient unit at the Fred
Hutchinson Cancer Research Center in Seattle during
a parainfluenza outbreak at the institution. The
authors observed a cluster of parainfluenza-3 genotypein outpatients, whereas this genotype was not found in
hospitalized patients receiving medical care during the
same period.
The main mechanism of RSV transmission
(namely, contact with surfaces that are contaminated
with the virus) favors transmission in hospitals [18].
During the study period, no hospital-acquired RSV
infection could be demonstrated in the inpatient
ward at the HSCTUnit. RSV infection was diagnosed
in patient TMO10231 2 days after admission to the
ward and was therefore considered to be community
acquired. However, other authors have shown that
the virus can be transmitted within inpatient wards
[2,3,6,10,19,20].
There are 2 major limitations in this study that
prevented a definitive conclusion about crosstransmis-
sion of RSV in the outpatient unit. First, we were
unable to characterize molecularly all the virus strains
Figure 3. Light gray squares indicate duration of RSV shedding; squares with black borders indicate the samples that were sequenced; N5 day of nasal
wash sampling;  5 period of hospital admission; V 5 visit to the outpatient unit without NW sampling; S 5 sequenced; NS 5 not sequenced.
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cases of RSV would probably be identified if PCR
was also performed on the NW samples. Second, clin-
ical samples from patients’ family members and from
employees at the HSCT unit were lacking. Conse-
quently, the whole transmission chain could not be
demonstrated, particularly in samples from 2001.
Patients can contract community-acquired infection
through contact with family members, especially those
familymembers under 12 years of age, andmay already
be infected when they arrive at the outpatient unit
[21,22]. Similarly, asymptomatic or oligosymptomatic
health staff can transmit the infection within the work
environment [21]. Although NWs were collected from
employees with symptoms of respiratory infection,
these samples were not stored for later analysis. One
case of RSV was detected in a HCW , and crosstrans-
mission may therefore have taken place, although this
could not be demonstrated.
HSCT recipients were infected with multiple
strains in 2001 and 2002, corroborating the findings
of Mazzulli et al. [2] and Englund et al. [19], who
also reported that multiple strains can be introduced
and spread in hospitals. As most of the patients were
not hospitalized, they were in contact with viruses cir-
culating in the community, which could explain the va-
riety of strains and genotypes in the HSCT outpatient
unit. As reviewed by Cane, in 2001 [23], the A and B
groups of RSV can circulate together in a community,
although group A strains predominate over group B
strains. Surprisingly, the strains analyzed from 2001
were mainly from group A, with GA2 as the predomi-
nant genotype followed by GA5; the predominant
strains circulating in the community in Sa˜o Paulo
that year were from group B. In 2002, the strains iso-
lated from HSCT recipients were mainly from group
B, and the predominant genotype was SAB3 followed
by SAB1; the predominant strains circulating in the
community were from group A (E.L. Durigon, data
not published). These data reinforce the hypothesis
of crosstransmission of RSV in the outpatient unit in
the present study. Another possible explanation is the
selective advantage of the virus, ensuring that geno-
types against which the community is probably
immune can circulate and persist in immunologically
compromised individuals [1,24].
In the present study, we observed that multiple
strains cocirculated in the hematopoietic stem cell
transplant unit (outpatient unit and inpatient ward)
at the Hospital das Clınicas, Sa˜o Paulo, in 2001 and
2002. The detection of phylogenetically related RSV
strains in the day hospital that were different from
the predominant community strains in circulation in
the respective years suggests the occurrence of RSV
transmission in the outpatient setting. Thus, strict
control measures should also be implemented as
much as possible in the outpatient setting, to avoidtransmission of RSV and other respiratory viruses
among HSCT recipients.ACKNOWLEDGMENTS
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